KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Net Income (2016 - 2025)

Zimmer Biomet Holdings has reported Net Income over the past 17 years, most recently at $137.9 million for Q4 2025.

  • Quarterly results put Net Income at $137.9 million for Q4 2025, down 28.33% from a year ago — trailing twelve months through Dec 2025 was $705.0 million (down 17.78% YoY), and the annual figure for FY2025 was $705.1 million, changed.
  • Net Income for Q4 2025 was $137.9 million at Zimmer Biomet Holdings, down from $231.2 million in the prior quarter.
  • Over the last five years, Net Income for ZBH hit a ceiling of $419.7 million in Q4 2023 and a floor of -$58.8 million in Q1 2022.
  • Median Net Income over the past 5 years was $172.8 million (2024), compared with a mean of $146.2 million.
  • Biggest five-year swings in Net Income: tumbled 1351.06% in 2022 and later skyrocketed 495.75% in 2023.
  • Zimmer Biomet Holdings' Net Income stood at -$29.2 million in 2021, then tumbled by 101.37% to -$58.8 million in 2022, then soared by 813.78% to $419.7 million in 2023, then plummeted by 54.16% to $192.4 million in 2024, then decreased by 28.33% to $137.9 million in 2025.
  • The last three reported values for Net Income were $137.9 million (Q4 2025), $231.2 million (Q3 2025), and $153.4 million (Q2 2025) per Business Quant data.